Prognostic significance of cytologic subdivision in nodular sclerosing Hodgkin’s disease: An analysis of 1156 patients
- 43 Downloads
Nodular sclerosis is the most commonly recognized histopathologic subtype of Hodgkin’s disease in many studies [1–5]. In the clinical trials of the British National Lymphoma Investigation (BNLI) , 75% of the cases have been classified as nodular sclerosis. Cellular nodules may have a wide variety of histologic appearances which may range from a predominance of lymphocytes to lymphocyte depletion with numerous Hodgkin’s cells . A clear need has emerged for further histopathologic subdivision within this group in order to provide additional prognostic information. Several reports on this theme have been published, but the numbers of cases examined in these studies have been rather small [8–13]. In two previous publications we described the prognostic significance of a cytologic subdivision of nodular sclerosing Hodgkin’s disease in a group of laparotomized or Stage IV patients  and in a group of patients who had not undergone staging laparotomy . We now present the combined results of our histologic analysis of 1156 cases of nodular sclerosing Hodgkin’s disease included in which are patients from the previous two studies. The prognostic significance of this cytologic subdivision is discussed and the relationship to anatomic stage is reviewed.
KeywordsActuarial Survival Lymphocyte Depletion Lacunar Cell Cytologic Appearance Peripheral Blood Lymphocyte Count
Unable to display preview. Download preview PDF.
- 2.Chelloul N, Burke J, Motteram R et al. (1972). HL-A antigens and Hodgkin’s disease. Report on the histological analysis. In: Histocompatibility Testing. Copenhagen: Munkgaard.Google Scholar
- 4.Kaplan HS (1980). Hodgkin’s Disease. 2nd ed. Cambridge. Mass.: Harvard University Press.Google Scholar
- 7.Noiman RS (1978). Current problems in the histopathological diagnosis and classification of Hodgkin’s disease. Path Ann 13: 289–328.Google Scholar
- 11.Cionini L, Argonini L, Biti GP and Bondi R (1978). Prognostic significance of histologic subdivision of Hodgkin’s disease nodular sclerosis. Acta Radiologica (Oncology) 17: 6573.Google Scholar
- 13.Mann RB, Jaffee ES and Berard CW (1979). Malignant lymphomas, a conceptual understanding of morphologic diversity. Amer J Path 94: 103–192.Google Scholar
- 18.Peto R, Pike MC, Armitage P et al. (1977). Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35: 1–39.Google Scholar
- 20.MacLennan KA, Vaughan Hudson B, Jelliffe AM et al. (1981). The pretreatment peripheral blood lymphocyte count in 1100 patient with Hodgkin’s disease: The prognostic significance and the relationship to the presence of systemic symptoms. Clin Oncol 7: 333–339.Google Scholar
- 21.Jackson H Jr and Parker F Jr (1947). Hodgkin’s Disease and Allied Disorders. New York: Oxford University Press.Google Scholar